| Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in children aged 2 to 5 [TSID10767] | Medicine | Not selected | |
| Lateral orbital decompression | Procedure | Not selected | |
| Coronary venous arterialisation in patients with refractory angina | Procedure | Not selected | |
| Perfusion-induced systemic hyperthermia for the treatment of advanced lung cancer | Procedure | Not selected | |
| Endovascular Arch Repair | Procedure | Not selected | |
| Innovative treatment of leakage and anastomotic insufficiency | Procedure | Awaiting decision | |
| Subcutaneous ravulizumab for treating paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome [TSID11820] | Medicine | Not selected | |
| CT-P39 (omalizumab biosimilar) for previously treated chronic spontaneous urticaria [TSID11832] | Medicine | Not selected | |
| Semaglutide for treating obesity-related heart failure with preserved ejection fraction [TSID11788] | Medicine | Not selected | |
| Subcutaneous efgartigmod for treating generalised myasthenia gravis [TSID11835] | Medicine | Not selected | |
| Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158) | Diagnostic | Not selected | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740) | Diagnostic | Not selected | |
| NPJ5008 for treating malignant hyperthermia [TSID11829] | Medicine | Not selected | |
| Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis | Procedure | Not selected | |
| Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis | Procedure | Not selected | |
| Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsy | Procedure | Not selected | |
| Magnetic compression anastomosis for rectal atresia | Procedure | Further information required | |
| Extradural motor cortex stimulation (EMCS) for Parkinson's disease | Procedure | Further information required | |
| Vascular Robotics | Procedure | Not selected | |
| Advanced Pelvic Exenteration surgery for complex pelvic cancers | Procedure | Not selected | |
| Focused Electrohydraulic Shockwaves for wound healing | Procedure | Not selected | |
| Emicizumab for preventing bleeding episodes in people with mild or moderate haemophilia A [ID5098] | Medicine | Not selected | |
| Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TSID10639] | Medicine | Not selected | |
| Ceftobiprole medocaril for treating community- or hospital-acquired pneumonia in people 3 months to 17 years [TSID11819] | Medicine | Not selected | |
| Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828] | Medicine | Not selected | |
| EUS guided portal pressure measurement | Procedure | Awaiting decision | |
| Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998] | Medicine | Not selected | |
| High-dose aflibercept for treating wet age-related macular degeneration [TSID10590] | Medicine | Not selected | |
| Aflibercept for untreated diabetic macular oedema [TSID10621] | Medicine | Not selected | |
| High intensity focused electromagnetic (HIFEM) energy to target the pelvic floor muscles | Procedure | Not selected | |
| Transcranial direct current stimulation (tDCS) for the treatment of refractory epilepsy | Procedure | Further information required | |
| Semaglutide for treating type 2 diabetes and associated peripheral arterial disease [TSID11791] | Medicine | Not selected | |
| Percutaneous Laser (Photo) Ablation of Liver Tumours | Procedure | Awaiting decision | |
| Stockholm3 blood test for prostate cancer, (MT734), | Diagnostic | Not selected | |
| Glucarpidase for reducing toxic plasma methotrexate levels in people aged 28 days and over [TSID10761] | Medicine | Not selected | |
| Sacubitril valsartan for treating chronic heart failure with reduced ejection fraction in people under 18 years [TSID10350] | Medicine | Not selected | |
| Circcurer Circumcision | Procedure | Not selected | |
| Advanced pelvic exenteration / high complexity pelvic exenteration | Procedure | Awaiting decision | |
| Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years [TSID11805] | Medicine | Not selected | |
| O2Matic pro 100 (MT746) | Device | Not selected | |
| Signatera molecular residual disease assay (MT741) | Device | Not selected | |
| ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis [TSID11790] | Medicine | Not selected | |
| Polydioxanone stents for the therapy of Tracheal stenosis: adults | Procedure | Awaiting decision | |
| DV7103 for treating cystinuria in people 6 months and over [TSID10438] | Medicine | Further information required | |
| Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ] | Medicine | Not selected | |
| Canakinumab for untreated Schnitzler syndrome [ID4063] | Medicine | Not selected | |
| Gender Affirmation Surgery: Masculinising - Metoidioplasty | Procedure | Not selected | |
| Teduglutide for treating short bowel syndrome in babies 4 to 12 months
[TSID10755] | Medicine | Not selected | |
| EchoLaser percutaneous laser ablation treatment for patients with neck lesions | Procedure | Not selected | |
| Botulinum toxin injection to cricopharyngeal muscle | Procedure | Not selected | |